Dr. Oleg Gligich
Claim this profileMount Sinai Medical Center
Area of expertise
Lung Cancer
Oleg Gligich has run 6 trials for Lung Cancer. Some of their research focus areas include:
Bladder Cancer
Oleg Gligich has run 4 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mount Sinai Medical Center
Mount Sinai Comprehensive Cancer Center At Aventura
Clinical Trials Oleg Gligich is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting
2 awards
Phase 3
19 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
More about Oleg Gligich
Clinical Trial Related
2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Oleg Gligich has experience with
- Carboplatin
- Pembrolizumab
- Atezolizumab
- Pemetrexed
- Durvalumab
- Nivolumab
Breakdown of trials Oleg Gligich has run
Lung Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Oleg Gligich specialize in?
Oleg Gligich focuses on Lung Cancer and Bladder Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Oleg Gligich currently recruiting for clinical trials?
Yes, Oleg Gligich is currently recruiting for 5 clinical trials in Miami Beach Florida. If you're interested in participating, you should apply.
Are there any treatments that Oleg Gligich has studied deeply?
Yes, Oleg Gligich has studied treatments such as Carboplatin, Pembrolizumab, Atezolizumab.
What is the best way to schedule an appointment with Oleg Gligich?
Apply for one of the trials that Oleg Gligich is conducting.
What is the office address of Oleg Gligich?
The office of Oleg Gligich is located at: Mount Sinai Medical Center, Miami Beach, Florida 33140 United States. This is the address for their practice at the Mount Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.